Home › Funds › HIGHBRIDGE CAPITAL MANAGEMENT LLC › DMII

HIGHBRIDGE CAPITAL MANAGEMENT LLC position in DMII

DRUGS MADE IN AMERICA ACQUISITION II CORP · Financials

HIGHBRIDGE CAPITAL MANAGEMENT LLC reported holding 2,241,215 shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) in its Q2 2026 13F filing — a position valued at US$22.6M, representing 0.91% of its reported portfolio and ranking #21 among its reported holdings. HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)2.24M sh
Reported value held$22.57M
Portfolio Weight0.91%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HIGHBRIDGE CAPITAL MANAGEMENT LLC's DMII position evolved

HIGHBRIDGE CAPITAL MANAGEMENT LLC first disclosed a stake in DMII in Q1 2026 at 225,004 shares (US$2.2M). The position peaked in Q2 2026 at 2,241,215 shares, worth US$22.6M. Across 2 filings, HIGHBRIDGE CAPITAL MANAGEMENT LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,241,215 shares valued at US$22.6M — an increase of 2,016,211 shares quarter over quarter.. Notable position changes include a 896% increase in Q2 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 225.00K $2.25M New
Q2 2026 2.24M $22.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) is a Financials company. 70 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.2M), MMCAP International Inc. SPC (US$27.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has HIGHBRIDGE CAPITAL MANAGEMENT LLC held DMII?

HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is HIGHBRIDGE CAPITAL MANAGEMENT LLC's current position in DMII?

As of Q2 2026, HIGHBRIDGE CAPITAL MANAGEMENT LLC holds 2.24M shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP), valued at $22.57M, representing 0.91% of its reported portfolio and ranking #21.

Has HIGHBRIDGE CAPITAL MANAGEMENT LLC been buying or selling DMII?

In the latest 13F filing (Q2 2026), HIGHBRIDGE CAPITAL MANAGEMENT LLC increased its position in DMII. The position peaked in Q2 2026 at 2.24M shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.